共 53 条
[1]
Hanna M(2014)Novel drugs targeting transthyretin amyloidosis Curr Heart Fail Rep 11 50-57
[2]
Hawkins PN(2015)Evolving landscape in the management of transthyretin amyloidosis Ann Med 47 625-638
[3]
Ando Y(2015)Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis J Cardiovasc Transl Res 8 117-127
[4]
Dispenzeri A(2013)THAOS – The Transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis Curr Med Res Opin 29 63-76
[5]
Gonzalez-Duarte A(2012)Transthyretin cardiac amyloidoses in older north Americans J Am Geriatr Soc 60 765-774
[6]
Adams D(2012)Transthyretin (TTR) cardiac amyloidosis Circulation. 126 1286-1300
[7]
Suhr OB(2012)Cardiac transthyretin amyloidosis Heart. 98 1546-1554
[8]
Damy T(2015)Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs Heart Fail Rev 20 163-178
[9]
Judge DP(1992)Familial amyloidosis: a study of 52 north American-born patients examined during a 30-year period Mayo Clin Proc 67 428-440
[10]
Kristen AV(1985)Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat J Biol Chem 260 11793-11798